678 related articles for article (PubMed ID: 29726480)
1. Intracoronary Nicorandil and the Prevention of the No-Reflow Phenomenon During Primary Percutaneous Coronary Intervention in Patients with Acute ST-Segment Elevation Myocardial Infarction.
Qi Q; Niu J; Chen T; Yin H; Wang T; Jiang Z
Med Sci Monit; 2018 May; 24():2767-2776. PubMed ID: 29726480
[TBL] [Abstract][Full Text] [Related]
2. [The effect on myocardial perfusion and clinical outcome of intracoronary nicorandil injection prior to percutaneous coronary intervention in ST-segment elevation myocardial infarction].
Wang ZQ; Chen MX; Liu DL; Zheng WX; Cao XZ; Chen H; Huang MF; Luo ZR
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):26-33. PubMed ID: 28100342
[No Abstract] [Full Text] [Related]
3. Effect of intracoronary agents on the no-reflow phenomenon during primary percutaneous coronary intervention in patients with ST-elevation myocardial infarction: a network meta-analysis.
Niu X; Zhang J; Bai M; Peng Y; Sun S; Zhang Z
BMC Cardiovasc Disord; 2018 Jan; 18(1):3. PubMed ID: 29320987
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of intracoronary prourokinase during percutaneous coronary intervention in treating ST-segment elevation myocardial infarction patients: a randomized, controlled study.
Wu Y; Fu X; Feng Q; Gu X; Hao G; Fan W; Jiang Y
BMC Cardiovasc Disord; 2020 Jun; 20(1):308. PubMed ID: 32590944
[TBL] [Abstract][Full Text] [Related]
5. Effects of intracoronary injection of nicorandil and tirofiban on myocardial perfusion and short-term prognosis in elderly patients with acute ST-segment elevation myocardial infarction after emergency PCI.
Chen GX; Wang HN; Zou JL; Yuan XX
World J Emerg Med; 2020; 11(3):157-163. PubMed ID: 32351648
[TBL] [Abstract][Full Text] [Related]
6. Effects of Early Intracoronary Administration of Nicorandil During Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction.
Feng C; Liu Y; Wang L; Niu D; Han B
Heart Lung Circ; 2019 Jun; 28(6):858-865. PubMed ID: 29891250
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the Efficacy and Safety of Early Intracoronary Nicorandil Administration in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Gupta H; Parihar S; Tripathi VD
Cureus; 2022 May; 14(5):e25349. PubMed ID: 35761910
[TBL] [Abstract][Full Text] [Related]
8. [Effects of pretreatment with recombinant human B-type natriuretic peptide on infarct size in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention].
Li S; Fu X; Dai Y; Liu C; Wang Y; Li W; Wu W; Gu X; Hao G; Fan W; Miao Q; Jiang Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2015 Nov; 43(11):954-9. PubMed ID: 26888806
[TBL] [Abstract][Full Text] [Related]
9. Intracoronary fixed dose of nitroprusside via thrombus aspiration catheter for the prevention of the no-reflow phenomenon following primary percutaneous coronary intervention in acute myocardial infarction.
Zhao YJ; Fu XH; Ma XX; Wang DY; Dong QL; Wang YB; Li W; Xing K; Gu XS; Jiang YF
Exp Ther Med; 2013 Aug; 6(2):479-484. PubMed ID: 24137212
[TBL] [Abstract][Full Text] [Related]
10. Effect of intracoronary nitroprusside injection on flow recovery during primary PCI in acute STEMI patients.
Yang L; Mu L; Sun L; Qi F; Guo R
Minerva Cardioangiol; 2017 Apr; 65(2):111-118. PubMed ID: 27249789
[TBL] [Abstract][Full Text] [Related]
11. Effect of intravenous application of nicorandil on area of myocardial infarction in patients with STEMI during the perioperative stage of PCI.
Wang ZD; Li H; Liu M; Li P; Chen J; Liang XW; Zhu XZ; Liao W
Clin Hemorheol Microcirc; 2021; 77(4):411-423. PubMed ID: 33386796
[TBL] [Abstract][Full Text] [Related]
12. Nicorandil prior to primary percutaneous coronary intervention improves clinical outcomes in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials.
Xu L; Wang L; Li K; Zhang Z; Sun H; Yang X
Drug Des Devel Ther; 2019; 13():1389-1400. PubMed ID: 31118574
[No Abstract] [Full Text] [Related]
13. Prophylactically injection of Nicorandil to reduce no-reflow phenomenon during PCI in acute STEMI patients: Protocol of a double-blinded, randomized, placebo-controlled trial.
An S; Huang H; Wang H; Jiang Y
Medicine (Baltimore); 2021 Apr; 100(15):e25500. PubMed ID: 33847663
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of nicorandil administration in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a systematic review and meta-analysis of randomized controlled trials.
Geng N; Ren L; Xu L; Zou D; Pang W
BMC Cardiovasc Disord; 2021 Oct; 21(1):488. PubMed ID: 34629058
[TBL] [Abstract][Full Text] [Related]
15. Myocardial Perfusion in ST-Segment Elevation Myocardial Infarction Patients After Percutaneous Coronary Intervention: Influencing Factors and Intervention Strategies.
Tang N; Chen X; Li K; Li H; Qi C
Cureus; 2023 Aug; 15(8):e42841. PubMed ID: 37538975
[TBL] [Abstract][Full Text] [Related]
16. Predictive value of admission red cell distribution width-platelet ratio for no-reflow phenomenon in acute ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Celık T; Balta S; Demır M; Yıldırım AO; Kaya MG; Ozturk C; Demırkol S; Unlu M; Kılıc S; Aydın İ; Iyısoy A
Cardiol J; 2016; 23(1):84-92. PubMed ID: 26503078
[TBL] [Abstract][Full Text] [Related]
17. Cardioprotective Effects of Nicorandil on Coronary Heart Disease Patients Undergoing Elective Percutaneous Coronary Intervention.
Pang Z; Zhao W; Yao Z
Med Sci Monit; 2017 Jun; 23():2924-2930. PubMed ID: 28617765
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular events associated with nicorandil administration prior to primary percutaneous coronary intervention in patients with acute ST-segment elevated myocardial infarction: a systematic review and meta-analysis.
Li J; Xu X; Zhou X; Dai J; Ma L; Chen C; Li X; Mao W
Expert Opin Drug Saf; 2019 Jun; 18(6):537-547. PubMed ID: 31117845
[No Abstract] [Full Text] [Related]
19. Coronary artery ectasia, an independent predictor of no-reflow after primary PCI for ST-elevation myocardial infarction.
Schram HCF; Hemradj VV; Hermanides RS; Kedhi E; Ottervanger JP;
Int J Cardiol; 2018 Aug; 265():12-17. PubMed ID: 29731349
[TBL] [Abstract][Full Text] [Related]
20. Elevated uric acid is related to the no-/slow-reflow phenomenon in STEMI undergoing primary PCI.
Hu X; Yang X; Li X; Li G; Zhou Y; Dong H
Eur J Clin Invest; 2022 Apr; 52(4):e13719. PubMed ID: 34800289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
